nach oben

Journal of Neuro-Oncology

Erschienen in:

01.09.2010 | Invited Review

Fractionated radiotherapy for intracranial meningiomas

verfasst von: Vinai Gondi, Wolfgang A. Tome, Minesh P. Mehta

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Fractionated external beam radiotherapy (EBRT) has multiple roles in the management of intracranial meningiomas. In multiple series post-operative EBRT has shown improved progression-free survival following subtotal resection and a reduction in long-term failures following an apparent gross total resection. In the definitive setting, the use of EBRT has increased as the growing utilization of neuro-imaging for various conditions identifies skull-based lesions which are not easily resectable. Optic nerve sheath meningiomas represent a classic example of the use of definitive EBRT, given the frequent visual sequelae of surgery or observation. EBRT planning is highly individualized and requires a detailed understanding of tumor grade, adjacent radiosensitive structures such as the anterior optic apparatus, and radiographic characteristics of the tumor such as hyperostosis.

Korshunov A, Shishkina L, Golanov A (2003) Immunohistochemical analysis of p16INK4a, p14ARF, p18INK4c, p21CIP1, p27KIP1 and p73 expression in 271 meningiomas correlation with tumor grade and clinical outcome. Int J Cancer 104:728–734CrossRefPubMed

Ho DM, Hsu CY, Ting LT, Chiang H (2002) Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer 94:1538–1547CrossRefPubMed

Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC (1999) “Malignancy” in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85:2046–2056PubMed

Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1997) Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21:1455–1465CrossRefPubMed

Perry A, Louis DN, Scheithauer BW, Budka H, von Deimling A (2007) Meningeal tumors. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) World health organization classification of tumors of the central nervous system. IARC Press, Lyon, pp 164–172

Louis DN, Scheithauer BW, Budka H (2000) Pathology and genetics of tumors of the nervous system. In: Kleihues P, Cavenee WK (eds) World health organization classification of tumours. IARC Press, Lyon, pp 176–184

Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB Jr, Rhoton AL (1997) Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 39:427–436PubMed

Nutting C, Brada M, Brazil L, Sibtain A, Saran F, Westbury C, Moore A, Thomas DG, Traish D, Ashley S (1999) Radiotherapy in the treatment of benign meningioma of the skull base. J Neurosurg 90:823–827CrossRefPubMed

Willis J, Smith C, Ironside JW, Erridge S, Whittle IR, Everington D (2005) The accuracy of meningioma grading: a 10-year retrospective audit. Neuropathol Appl Neurobiol 31:141–149CrossRefPubMed

10.

Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM (2005) Epidemiology of intracranial meningioma. Neurosurgery 57:1088–1095; discussion 1088–1095CrossRefPubMed

11.

Perry A (2006) Meningiomas. In: McLendon R, Rosenblum M, Bigner DD (eds) Russel & Rubinsten’s pathology of tumors of the nervous system. Hodder Arnold, London, pp 427–474

12.

Jaaskelainen J, Haltia M, Servo A (1986) Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25:233–242CrossRefPubMed

13.

Perry A (2004) Unmasking the secrets of meningioma: a slow but rewarding journey. Surg Neurol 61:171–173CrossRefPubMed

14.

Hug EB, Devries A, Thornton AF, Munzenride JE, Pardo FS, Hedley-Whyte ET, Bussiere MR, Ojemann R (2000) Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol 48:151–160CrossRefPubMed

15.

Perry A, Gutmann DH, Reifenberger G (2004) Molecular pathogenesis of meningiomas. J Neurooncol 70:183–202CrossRefPubMed

16.

Adegbite AB, Khan MI, Paine KW, Tan LK (1983) The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 58:51–56CrossRefPubMed

17.

King DL, Chang CH, Pool JL (1966) Radiotherapy in the management of meningiomas. Acta Radiol Ther Phys Biol 3:26–33PubMed

18.

Yamashita J, Handa H, Iwaki K, Abe M (1980) Recurrence of intracranial meningiomas, with special reference to radiotherapy. Surg Neurol 14:33–40PubMed

19.

Glaholm J, Bloom HJ, Crow JH (1990) The role of radiotherapy in the management of intracranial meningiomas: the Royal Marsden Hospital experience with 186 patients. Int J Radiat Oncol Biol Phys 18:755–761PubMed

20.

Ron E, Modan B, Boice JD Jr (1988) Mortality after radiotherapy for ringworm of the scalp. Am J Epidemiol 127:713–725PubMed

21.

Ron E, Modan B, Boice JD Jr, Alfandary E, Stovall M, Chetrit A, Katz L (1988) Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 319:1033–1039CrossRefPubMed

22.

Strojan P, Popovic M, Jereb B (2000) Secondary intracranial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature. Int J Radiat Oncol Biol Phys 48:65–73CrossRefPubMed

23.

Flint-Richter P, Sadetzki S (2007) Genetic predisposition for the development of radiation-associated meningioma: an epidemiological study. Lancet Oncol 8:403–410CrossRefPubMed

24.

Stafford SL, Perry A, Suman VJ, Meyer FB, Scheithauer BW, Lohse CM, Shaw EG (1998) Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc 73:936–942CrossRefPubMed

25.

Jung HW, Yoo H, Paek SH, Choi KS (2000) Long-term outcome and growth rate of subtotally resected petroclival meningiomas: experience with 38 cases. Neurosurgery 46:567–574; discussion 574–565CrossRefPubMed

26.

keyson EW, McCutcheon IE (1996) Management of benign and aggressive intracranial meningiomas. Oncology (Williston Park) 10:747–756; discussion 756–749

27.

Goyal LK, Suh JH, Mohan DS, Prayson RA, Lee J, Barnett GH (2000) Local control and overall survival in atypical meningioma: a retrospective study. Int J Radiat Oncol Biol Phys 46:57–61CrossRefPubMed

28.

Coke CC, Corn BW, Werner-Wasik M, Xie Y, Curran WJ Jr (1998) Atypical and malignant meningiomas: an outcome report of seventeen cases. J Neurooncol 39:65–70CrossRefPubMed

29.

Henzel M, Gross MW, Hamm K, Surber G, Kleinert G, Failing T, Strassmann G, Engenhart-Cabillic R (2006) Stereotactic radiotherapy of meningiomas: symptomatology, acute and late toxicity. Strahlenther Onkol 182:382–388CrossRefPubMed

30.

Milker-Zabel S, Zabel A, Schulz-Ertner D, Schlegel W, Wannenmacher M, Debus J (2005) Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors. Int J Radiat Oncol Biol Phys 61:809–816PubMed

31.

Milker-Zabel S, Zabel-du Bois A, Huber P, Schlegel W, Debus J (2007) Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution. Int J Radiat Oncol Biol Phys 68:858–863PubMed

32.

Debus J, Wuendrich M, Pirzkall A, Hoess A, Schlegel W, Zuna I, Engenhart-Cabillic R, Wannenmacher M (2001) High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. J Clin Oncol 19:3547–3553PubMed

33.

Maguire PD, Clough R, Friedman AH, Halperin EC (1999) Fractionated external-beam radiation therapy for meningiomas of the cavernous sinus. Int J Radiat Oncol Biol Phys 44:75–79CrossRefPubMed

34.

Pirzkall A, Debus J, Haering P, Rhein B, Grosser KH, Hoss A, Wannenmacher M (2003) Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience. Int J Radiat Oncol Biol Phys 55:362–372PubMed

35.

Turbin RE, Pokorny K (2004) Diagnosis and treatment of orbital optic nerve sheath meningioma. Cancer Control 11:334–341PubMed

36.

Smith JL, Vuksanovic MM, Yates BM, Bienfang DC (1981) Radiation therapy for primary optic nerve meningiomas. J Clin Neuroophthalmol 1:85–99PubMed

37.

Turbin RE, Thompson CR, Kennerdell JS, Cockerham KP, Kupersmith MJ (2002) A long-term visual outcome comparison in patients with optic nerve sheath meningioma managed with observation, surgery, radiotherapy, or surgery and radiotherapy. Ophthalmology 109:890–899; discussion 899–900CrossRefPubMed

38.

Narayan S, Cornblath WT, Sandler HM, Elner V, Hayman JA (2003) Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys 56:537–543CrossRefPubMed

39.

Smee RI, Schneider M, Williams JR (2009) Optic nerve sheath meningiomas–non-surgical treatment. Clin Oncol (R Coll Radiol) 21:8–13

40.

Baumert BG, Villa S, Studer G, Mirimanoff RO, Davis JB, Landau K, Ducrey N, Arruga J, Lambin P, Pica A (2004) Early improvements in vision after fractionated stereotactic radiotherapy for primary optic nerve sheath meningioma. Radiother Oncol 72:169–174CrossRefPubMed

41.

Andrews BT, Wilson CB (1988) Suprasellar meningiomas: the effect of tumor location on postoperative visual outcome. J Neurosurg 69:523–528CrossRefPubMed

42.

Liu JK, Forman S, Hershewe GL, Moorthy CR, Benzil DL (2002) Optic nerve sheath meningiomas: visual improvement after stereotactic radiotherapy. Neurosurgery 50:950–955; discussion 955–957CrossRefPubMed

43.

Becker G, Jeremic B, Pitz S, Buchgeister M, Wilhelm H, Schiefer U, Paulsen F, Zrenner E, Bamberg M (2002) Stereotactic fractionated radiotherapy in patients with optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys 54:1422–1429PubMed

44.

Pitz S, Becker G, Schiefer U, Wilhelm H, Jeremic B, Bamberg M, Zrenner E (2002) Stereotactic fractionated irradiation of optic nerve sheath meningioma: a new treatment alternative. Br J Ophthalmol 86:1265–1268CrossRefPubMed

45.

Saeed P, Rootman J, Nugent RA, White VA, Mackenzie IR, Koornneef L (2003) Optic nerve sheath meningiomas. Ophthalmology 110:2019–2030CrossRefPubMed

46.

Augspurger ME, The BS, Uhl BM, Lee AG, Grant WH, Butler EB, Woo SY (1999) Conformal intensity modulated radiation therapy for the treatment of optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys 45(suppl):324 abstract

47.

Tsao MN, Hoyt WF, Horton J, Bahary JP, Wara WM, Akazawa C, Larson DA (1999) Improved visual outcome with definitive radiation therapy for optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys 45(3 suppl):324 abstract

48.

Kennerdell JS, Maroon JC, Malton M, Warren FA (1988) The management of optic nerve sheath meningiomas. Am J Ophthalmol 106:450–457PubMed

49.

Kupersmith MJ, Warren FA, Newall J, Ransohoff J (1987) Irradiation of meningiomas of the intracranial anterior visual pathway. Ann Neurol 21:131–137CrossRefPubMed

50.

Berman D, Miller NR (2006) New concepts in the management of optic nerve sheath meningiomas. Ann Acad Med Singapore 35:168–174PubMed

51.

Pollock BE, Stafford SL, Utter A, Giannini C, Schreiner SA (2003) Stereotactic radiosurgery provides equivalent tumor control to Simpson Grade 1 resection for patients with small- to medium-size meningiomas. Int J Radiat Oncol Biol Phys 55:1000–1005PubMed

52.

Kondziolka D, Flickinger JC, Perez B (1998) Judicious resection and/or radiosurgery for parasagittal meningiomas: outcomes from a multicenter review. Gamma Knife Meningioma Study Group. Neurosurgery 43:405–413; discussion 413–404

53.

Borovich B, Doron Y (1986) Recurrence of intracranial meningiomas: the role played by regional multicentricity. J Neurosurg 64:58–63CrossRefPubMed

54.

Nagele T, Petersen D, Klose U, Grodd W, Opitz H, Voigt K (1994) The “dural tail” adjacent to meningiomas studied by dynamic contrast-enhanced MRI: a comparison with histopathology. Neuroradiology 36:303–307CrossRefPubMed

55.

Kawahara Y, Niiro M, Yokoyama S, Kuratsu J (2001) Dural congestion accompanying meningioma invasion into vessels: the dural tail sign. Neuroradiology 43:462–465CrossRefPubMed

56.

Ahmadi J, Hinton DR, Segall HD, Couldwell WT (1994) Surgical implications of magnetic resonance-enhanced dura. Neurosurgery 35:370–377; discussion 377CrossRefPubMed

57.

DiBiase SJ, Kwok Y, Yovino S, Arena C, Naqvi S, Temple R, Regine WF, Amin P, Guo C, Chin LS (2004) Factors predicting local tumor control after gamma knife stereotactic radiosurgery for benign intracranial meningiomas. Int J Radiat Oncol Biol Phys 60:1515–1519PubMed

58.

Sibtain A, Plowman PN (1999) Stereotactic radiosurgery. VII. Radiosurgery versus conventionally-fractionated radiotherapy in the treatment of cavernous sinus meningiomas. Br J Neurosurg 13:158–166CrossRefPubMed

59.

Goldsmith B (1998) Meningioma. In: Leibel SA, Phillips TS (eds) Textbook of radiation oncology. WB Saunders, Philadelphia, pp 324–340

60.

Simpson D (1957) Graded resection extent based upon clinically apparent recurrence of intracranial meningioma in 265 patients from Radcliffe Infirmary in Oxford as well as patients from Dr. Hugh Cairns in London. J Neurol Neurosurg Psychiat 20:22–39CrossRefPubMed

61.

Goldsmith BJ, Wara WM, Wilson CB, Larson DA (1994) Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 80:195–201CrossRefPubMed

62.

Milosevic MF, Frost PJ, Laperriere NJ, Wong CS, Simpson WJ (1996) Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys 34:817–822PubMed

63.

Barbaro NM, Gutin PH, Wilson CB, Sheline GE, Boldrey EB, Wara WM (1987) Radiation therapy in the treatment of partially resected meningiomas. Neurosurgery 20:525–528CrossRefPubMed

64.

Taylor BW Jr, Marcus RB Jr, Friedman WA, Ballinger WE Jr, Million RR (1988) The meningioma controversy: postoperative radiation therapy. Int J Radiat Oncol Biol Phys 15:299–304PubMed

65.

Goldsmith BJ, Rosenthal SA, Wara WM, Larson DA (1992) Optic neuropathy after irradiation of meningioma. Radiology 185:71–76PubMed

66.

Shrieve DC, Hazard L, Boucher K, Jensen RL (2004) Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance. J Neurosurg 101(Suppl 3):390–395PubMed

67.

Miralbell R, Linggood RM, de la Monte S, Convery K, Munzenrider JE, Mirimanoff RO (1992) The role of radiotherapy in the treatment of subtotally resected benign meningiomas. J Neurooncol 13:157–164CrossRefPubMed

68.

Uy NW, Woo SY, Teh BS, Mai WY, Carpenter LS, Chiu JK, Lu HH, Gildenberg P, Trask T, Grant WH, Butler EB (2002) Intensity-modulated radiation therapy (IMRT) for meningioma. Int J Radiat Oncol Biol Phys 53:1265–1270CrossRefPubMed

69.

al-Mefty O, Kersh JE, Routh A, Smith RR (1990) The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg 73:502–512CrossRefPubMed

70.

Paek SH, Kim CY, Kim YY, Park IA, Kim MS, Kim DG, Jung HW (2002) Correlation of clinical and biological parameters with peritumoral edema in meningioma. J Neurooncol 60:235–245CrossRefPubMed

71.

Steinvorth S, Welzel G, Fuss M, Debus J, Wildermuth S, Wannenmacher M, Wenz F (2003) Neuropsychological outcome after fractionated stereotactic radiotherapy (FSRT) for base of skull meningiomas: a prospective 1-year follow-up. Radiother Oncol 69:177–182CrossRefPubMed

72.

Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL (1985) Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62:18–24CrossRefPubMed

73.

Mahmood A, Qureshi NH, Malik GM (1994) Intracranial meningiomas: analysis of recurrence after surgical treatment. Acta Neurochir (Wien) 126:53–58CrossRef

74.

Peele KA, Kennerdell JS, Maroon JC, Kalnicki S, Kazim M, Gardner T, Malton M, Goodglick T, Rosen C (1996) The role of postoperative irradiation in the management of sphenoid wing meningiomas. A preliminary report. Ophthalmology 103:1761–1766; discussion 1766–1767PubMed

75.

Vendrely V, Maire JP, Darrouzet V, Bonichon N, San Galli F, Celerier D, Causse N, Demeaux H, Trouette R, Dahan O, Recaldini L, Guerin J, Caudry M (1999) Fractionated radiotherapy of intracranial meningiomas: 15 years’ experience at the Bordeaux University Hospital Center. Cancer Radiother 3:311–317PubMed

76.

Wenkel E, Thornton AF, Finkelstein D, Adams J, Lyons S, De La Monte S, Ojeman RG, Munzenrider JE (2000) Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys 48:1363–1370PubMed

77.

Pourel N, Auque J, Bracard S, Hoffstetter S, Luporsi E, Vignaud JM, Bey P (2001) Efficacy of external fractionated radiation therapy in the treatment of meningiomas: a 20-year experience. Radiother Oncol 61:65–70CrossRefPubMed

78.

Dufour H, Muracciole X, Metellus P, Regis J, Chinot O, Grisoli F (2001) Long-term tumor control and functional outcome in patients with cavernous sinus meningiomas treated by radiotherapy with or without previous surgery: is there an alternative to aggressive tumor removal? Neurosurgery 48:285–294; discussion 294–286CrossRefPubMed

79.

Jalali R, Loughrey C, Baumert B, Perks J, Warrington AP, Traish D, Ashley S, Brada M (2002) High precision focused irradiation in the form of fractionated stereotactic conformal radiotherapy (SCRT) for benign meningiomas predominantly in the skull base location. Clin Oncol (R Coll Radiol) 14:103–109

80.

Soyuer S, Chang EL, Selek U, Shi W, Maor MH, DeMonte F (2004) Radiotherapy after surgery for benign cerebral meningioma. Radiother Oncol 71:85–90CrossRefPubMed

81.

Selch MT, Ahn E, Laskari A, Lee SP, Agazaryan N, Solberg TD, Cabatan-Awang C, Frighetto L, Desalles AA (2004) Stereotactic radiotherapy for treatment of cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys 59:101–111PubMed

Titel: Fractionated radiotherapy for intracranial meningiomas
verfasst von: Vinai Gondi
Wolfgang A. Tome
Minesh P. Mehta
Publikationsdatum: 01.09.2010
Verlag: Springer US
Erschienen in: Journal of Neuro-Oncology / Ausgabe 3/2010
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-010-0368-5

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2010

Pathological classification and molecular genetics of meningiomas

Medical therapies for meningiomas

Opportunities for clinical research in meningioma

Aberrant signaling pathways in meningiomas

FACT-MNG: tumor site specific web-based outcome instrument for meningioma patients